Cargando…

Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models

Bone sarcomas have not shown a significant improvement in survival for decades, due, in part, to the development of resistance to current systemic treatments, such as doxorubicin. To better understand those mechanisms mediating drug-resistance we generated three osteosarcoma and one chondrosarcoma c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallego, Borja, Murillo, Dzohara, Rey, Verónica, Huergo, Carmen, Estupiñán, Óscar, Rodríguez, Aida, Tornín, Juan, Rodríguez, René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224263/ https://www.ncbi.nlm.nih.gov/pubmed/35742867 http://dx.doi.org/10.3390/ijms23126425

Ejemplares similares

Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
por: Murillo, Dzohara, et al.
Publicado: (2023)

Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
por: Menéndez, Sofía T., et al.
Publicado: (2021)

Proof of concept for the use of trained sniffer dogs to detect osteosarcoma
por: Ortal, Agustín, et al.
Publicado: (2022)

Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Mithramycin delivery systems to develop effective therapies in sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based Chemotherapy
por: Merimsky, Ofer, et al.
Publicado: (2000)

New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth
por: Rey, Veronica, et al.
Publicado: (2019)

Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2016)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models()
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2017)

Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
por: Tornin, Juan, et al.
Publicado: (2019)

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)

SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
por: Menendez, Sofia T., et al.
Publicado: (2020)

GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
por: Carrillo-Gálvez, Ana Belén, et al.
Publicado: (2020)

Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line
por: Wang, Feng, et al.
Publicado: (2017)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway()
por: Tornin, Juan, et al.
Publicado: (2017)

Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
por: Giacomini, Isabella, et al.
Publicado: (2023)

Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
por: Fujiwara, Tomohiro, et al.
Publicado: (2016)

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group
por: Nielsen, Ole S., et al.
Publicado: (2000)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas
por: Villar, Victor Hugo, et al.
Publicado: (2012)

Noncoding RNA in drug resistant sarcoma
por: Li, Xiaoyang, et al.
Publicado: (2017)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Essential Oils, Pituranthos chloranthus and Teucrium ramosissimum, Chemosensitize Resistant Human Uterine Sarcoma MES-SA/Dx5 Cells to Doxorubicin by Inducing Apoptosis and Targeting P-Glycoprotein
por: Lahmar, Aida, et al.
Publicado: (2021)

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
por: HUANG, LIMIN, et al.
Publicado: (2015)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
por: Wen, Chunjie, et al.
Publicado: (2019)

MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
por: Packeiser, Eva-Maria, et al.
Publicado: (2023)

Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
por: Christowitz, Claudia, et al.
Publicado: (2019)

The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012)

Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
por: Xu, Feifei, et al.
Publicado: (2014)

Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae
por: Bristow, Claire C., et al.
Publicado: (2016)

Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
por: Chen, Huan-Huan, et al.
Publicado: (2022)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
por: Krausz, Aimee E., et al.
Publicado: (2018)

The Molecular Mechanisms of Oleanane Aldehyde-β-enone Cytotoxicity against Doxorubicin-Resistant Cancer Cells
por: Moiseeva, Natalia, et al.
Publicado: (2023)

A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
por: Trucco, Matteo M., et al.
Publicado: (2018)

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
por: Savani, Malvi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_68ptb50nsvu8nqefl39p1dtk5o